Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,525 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Poly(2-ethyl-2-oxazoline)-Conjugated Hemoglobins as a Red Blood Cell Substitute.
Okamoto W, Hiwatashi Y, Kobayashi T, Morita Y, Onozawa H, Iwazaki M, Kohno M, Tomiyasu H, Tochinai R, Georgieva R, Bäumler H, Komatsu T. Okamoto W, et al. Among authors: kobayashi t. ACS Appl Bio Mater. 2023 Aug 21;6(8):3330-3340. doi: 10.1021/acsabm.3c00392. Epub 2023 Jul 28. ACS Appl Bio Mater. 2023. PMID: 37504970
Core-Shell Structured Hemoglobin Nanoparticles as Artificial O2 Carriers.
Okamoto W, Hasegawa M, Kohyama N, Kobayashi T, Usui T, Onozawa H, Hashimoto R, Iwazaki M, Kohno M, Georgieva R, Bäumler H, Komatsu T. Okamoto W, et al. Among authors: kobayashi t. ACS Appl Bio Mater. 2022 Dec 19;5(12):5844-5853. doi: 10.1021/acsabm.2c00813. Epub 2022 Nov 18. ACS Appl Bio Mater. 2022. PMID: 36399036
Polyoxazoline-conjugated porcine serum albumin as an artificial plasma expander for dogs.
Okamoto W, Usui T, Hasegawa M, Kobayashi T, Fujisawa J, Taguchi K, Matsumoto K, Kohno M, Iwazaki M, Shimano S, Nagao I, Toyoda H, Matsumura N, Tomiyasu H, Tochinai R, Komatsu T. Okamoto W, et al. Among authors: kobayashi t. Sci Rep. 2023 Jun 14;13(1):9512. doi: 10.1038/s41598-023-35999-4. Sci Rep. 2023. PMID: 37316550 Free PMC article.
J-AVENUE: A retrospective, real-world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first-line maintenance therapy in Japan.
Kikuchi E, Hayakawa N, Nakayama M, Uno M, Nakatsu H, Kitagawa C, Miyake H, Yamada T, Fujita K, Shimoyama H, Nishihara K, Kobayashi M, Nakamura M, Fujimoto K, Sano T, Nishiyama N, Ito T, Kajita M, Kobayashi T, Kitamura H. Kikuchi E, et al. Among authors: kobayashi t. Int J Urol. 2024 May 9. doi: 10.1111/iju.15473. Online ahead of print. Int J Urol. 2024. PMID: 38722221
14,525 results
You have reached the last available page of results. Please see the User Guide for more information.